NDUFAB1 and cancer: The workflow, outlined in Figure 1, includes several key steps: data collection and preprocessing, analysis of ACP features, construction of a novel prediction model, evaluation of the model’s performance, identification of natural candidate ACPs through multiple predictive tools, and validation of ACPs’ selective cytotoxicity against specific cancer cells.